BGM Group (NASDAQ:BGM) Shares Up 6.3% – Here’s Why

BGM Group Ltd. (NASDAQ:BGM)’s stock price shot up 6.3% during trading on Tuesday . The company traded as high as $0.3629 and last traded at $0.3401. 296,371 shares were traded during mid-day trading, a decline of 29% from the average session volume of 419,803 shares. The stock had previously closed at $0.3199.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of BGM Group in a report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, BGM Group presently has an average rating of “Sell”.

BGM Group Price Performance

The stock’s fifty day moving average is $0.32 and its two-hundred day moving average is $2.26.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Marshall Wace LLP bought a new stake in shares of BGM Group during the 2nd quarter worth about $218,000. Mariner LLC bought a new position in BGM Group during the 3rd quarter valued at $267,000. Finally, Geode Capital Management LLC acquired a new position in shares of BGM Group during the 2nd quarter valued at $412,000.

About BGM Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.